logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Drug Discovery Today cover

Drug Discovery Today

IF7.5
Papers6426
Citations22703
Journal Papers 7162
Publication Date
delete
Paradigm shift in the management of drug development projects: artificial-intelligence-enabled parallel scenario execution for managing uncertainty
deleteDrug Discovery Today
IF7.5
delete2026-09-28
delete0
PREAI
deleteShinichi Tsuchiwata; Misaki Ishii; Takahiko Aoyama; Yasuhiro Tsuji
deleteShare
deleteSave
Chemoproteomics in covalent cancer drug discovery
deleteDrug Discovery Today
IF7.5
delete2026-09-25
delete0
deleteOAAI
deleteJohn-Paul Ong; Montana Dalziel; Dona Johns; Joshua Zhu; Jean Bertoldo
deleteShare
deleteSave
Strength of weakness in molecular interactions: toward transient medicines in drug discovery
deleteDrug Discovery Today
IF7.5
delete2026-09-25
delete0
deleteOAAI
deleteSten Ohlson
deleteShare
deleteSave
The endothelin system: a potential target for the treatment of type 2 diabetes mellitus and associated cardiometabolic complications
deleteDrug Discovery Today
IF7.5
delete2026-09-25
delete0
PREAI
deleteMd Moklesur Rahman Sarker; Md.Nurul Islam; Nimi P. Simon; Tariful Islam; A.Z.M. Naser; Sherif Hafez; Raquibul Hasan
deleteShare
deleteSave
Patient-based evidence in mechanism-based drug repurposing: Challenges and recommendations
deleteDrug Discovery Today
IF7.5
delete2026-09-25
delete0
deleteOAAI
deleteMerel Kimman; Manuela Joore; Sabine Grimm
deleteShare
deleteSave
5-HT7 receptor as a potential therapeutic target in irritable bowel syndrome: Current insights and future perspectives
deleteDrug Discovery Today
IF7.5
delete2026-09-24
delete0
deleteOAAI
deleteZuzanna Kasprzak; Maria Jaczynska; Julia Jarzabek; Maciej Salaga
deleteShare
deleteSave
Erratum to “Major objections in EU medicines authorisation applications: an analysis of dossier submissions by small- and medium-sized enterprises” [Drug Discov. Today 31(4) (2026) 104721]
deleteDrug Discovery Today
IF7.5
delete2026-09-23
delete0
PREAI
deleteEglantine Legros; Leonor Enes; Constantinos Ziogas
deleteShare
deleteSave
deleteDrug Discovery Today
IF7.5
delete2026-09-23
delete0
PREAI
deleteXingxian Luo; Xin Du; Jiayue Xiao; Xiaonan Liu; Lin Huang; Xiaohong Zhang
deleteShare
deleteSave
Drug discovery strategies targeting B7-H3 (CD276) in lung and gastric cancers: From biological validation to next-generation small molecules, biologics and cell-based immunotherapies
deleteDrug Discovery Today
IF7.5
delete2026-09-23
delete0
PREAI
deleteSoorya Suresh; Surabhi Maurya; Kajal Singh; Kapil Sharma; Subhechchha Bar; Aastha Dagar; Vivek Uttam; Sandeep Singh; Farman Ahmad; Manju Jain; Raj Kumar; Gautam Sethi; Aklank Jain
deleteShare
deleteSave
Dark proteome and emerging technologies for functional characterization and drug discovery
deleteDrug Discovery Today
IF7.5
delete2026-09-17
delete0
PREAI
deleteMd Azizul Haque; Jong-Joo Kim; null Danishuddin
deleteShare
deleteSave
Pathway-driven target prioritisation in drug discovery
deleteDrug Discovery Today
IF7.5
delete2026-09-16
delete0
PREAI
deletePolina Rusina; David Ochoa; Franck Rapaport; Shameer Khader; Ellen M. McDonagh
deleteShare
deleteSave
From implicit prioritization to auditable decisions in natural product drug discovery
deleteDrug Discovery Today
IF7.5
delete2026-09-14
delete0
deleteOAAI
deleteAmit Gangwal; Antonio Lavecchia
deleteShare
deleteSave
Synthetic lethality and context-selective DNA-damage response dependencies: from genetic vulnerability to pharmacological translation
deleteDrug Discovery Today
IF7.5
delete2026-09-11
delete0
deleteOAAI
deleteNayoon Jo; Su-Jin Kang; Jeongeun Kim; Kwan Hyi Lee; Sunbok Jang
deleteShare
deleteSave
Effector-cell-engaging bispecific antibodies for cancer therapeutics: engineering precision immunity
deleteDrug Discovery Today
IF7.5
delete2026-09-09
delete0
deleteOAAI
deleteAmol D Gholap; Pankaj R Khuspe; Darshana Morankar; Navnath T Hatvate; Nanasaheb D Thorat
deleteShare
deleteSave
Estimating and predicting clinical trial outcomes in China
deleteDrug Discovery Today
IF7.5
delete2026-09-09
delete0
PREAI
deleteChaoyi Zhao; Timothy Pang; Andrew W. Lo
deleteShare
deleteSave
Leveraging precompetitive collaborations for rare diseases
deleteDrug Discovery Today
IF7.5
delete2026-09-08
delete0
PREAI
deleteVinciane Pirard
deleteShare
deleteSave
Artificial intelligence-enabled induced-proximity drug discovery: Designing productive molecular associations
deleteDrug Discovery Today
IF7.5
delete2026-09-07
delete0
PREAI
deleteHaomin Wu; Yaxin Xu; Zhiwei Nie; Zhongyang Zhou; Zhengyu Ma; Zhixiang Ren
deleteShare
deleteSave
Mutant isocitrate dehydrogenase in cancer: Structural biology, small-molecule inhibitors, and future drug discovery strategies
deleteDrug Discovery Today
IF7.5
delete2026-09-06
delete0
PREAI
deleteMoataz A. Shaldam; Anwar A. El-Hamaky; Nourhan A. Khattab; Salma M. Hefny; Mohamed S. Nafie; Wagdy M. Eldehna; Haytham O. Tawfik
deleteShare
deleteSave
The shelved pipeline: AI can find strategically abandoned medicines and bring them to patients
deleteDrug Discovery Today
IF7.5
delete2026-09-06
delete0
PREAI
deleteOre Arowojolu
deleteShare
deleteSave
From chemical space to synthetic reality: A framework for makeable-by-design generative AI in drug discovery
deleteDrug Discovery Today
IF7.5
delete2026-09-03
delete0
deleteOAAI
deleteSebastián O. Simonetti; Aldana B. Moroni; Maria Marta Zanardi; Frank Kozielski; Geoffrey Wells; Exequiel O.J. Porta
deleteShare
deleteSave